A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

NCT00545402 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Mycophenolate mofetil, adjusted dose
DRUG: Tacrolimus
DRUG: Corticosteroids, IV
DRUG: Mycophenolate mofetil, Standard dose
DRUG: Corticosteroids, PO

Sponsor

Hoffmann-La Roche